Follow-On Biologics To Get Hearing In Energy & Commerce/Health Subcommittee This Year
This article was originally published in The Pink Sheet Daily
Executive Summary
Chairman Nathan Deal (R-Ga.) also plans to hold a hearing on the generic drug application backlog at FDA.